Maynard Um
-
-
-
-
-
-
-
Alvotech SA (ALVO) PT Lowered to $6 at UBS, Stock Expected to Rerate as Visibility Improves
-
-
-
-
-
-
-
Alvotech secures $100 million term loan facility
-
-
-
-
-
-
-
Alvotech wins UK court ruling for Eylea biosimilar manufacturing
-
-
-
-
-
-
-
European regulator recommends Alvotech's denosumab biosimilar
-
-
-
-
-
-
-
Alvotech (ALVO) Announces Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair
-
-
-
-
-
-
-
Northland Reiterates Outperform Rating on Alvotech SA (ALVO)
-
-
-
-
-
-
-
Alvotech (ALVO) and Teva (TEVA) Announce U.S. FDA Approval of Additional Presentation of SELARSDI, Expanding its Label
-
445,079 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

